Latest Industry Insights

Join us for an interview with HP's Christie Dudenhoefer, manager of Life Science Solutions, and Dr. Ryan Kelly, professor in the Department of Chemistry at Brigham Young University, to learn how HP's D100 single-cell dispenser is being utilized.

Technology Networks spoke to the CEO of the Novo Nordisk Foundation Cellerator, Dr. Thomas H.R. Carlsen, to find out more about their new world-class facility that will focus on upscaling cell therapy development.

Technology Networks spoke to Dr. Jasper Van Hoorick to learn more about the future of bioprinting, the benefits of animal-free bioinks and the development of human tissue-based bioinks.

We spoke to Amit Patel, product marketing director at PacBio, to learn more about PacBio Compatible, the new collaborations and what benefits they will bring to customers.

In this op-ed, Markus Gershater delves into different aspects of the data we’ll need to generate to help us truly understand the biological systems we deal with.

A recent study has shown the clinical value of proactive, sequencing-based screening in apparently healthy newborns for medically actionable conditions. How might these findings impact the current NBS landscape and what does it mean to the healthcare system on the global level?

With growing sustainability demands, companies are looking for ways to demonstrate their green credentials. We spoke to Dr. Michael Frank to find out what ACT accreditation means for a company and why he thinks schemes like this are so important.

Scientists around the world are increasingly aware of the environmental footprint of their laboratories, and many are adjusting the way they work day-to-day to offset this impact. In this Industry Insights interview, Agilent's Dr. Michael Frank discusses the safety and efficiency considerations that are fundamentally linked to sustainability and considers why more labs aren’t utilizing consulting services to help them achieve their sustainability goals.

How can the industry as a whole address sustainability issues? What are the key needs and goals of pharma and biopharma laboratories when it comes to sustainability?

Rob Thomas shares some insights about what we can expect from the fourth edition of his book, "Practical Guide to ICP-MS and Other AS Techniques: A Tutorial for Beginners".